Abstract
The KK obese mouse is moderately obese and has abnormally high levels of plasma insulin (hyperinsulinemia), glucose (hyperglycemia) and lipids (hyperlipidemia). In one strain (KK/San), we observed abnormally low plasma lipid levels (hypolipidemia). This mutant phenotype is inherited recessively as a mendelian trait. Here we report the mapping of the hypolipidemia (hypl) locus to the middle of chromosome 4 and positional cloning of the autosomal recessive mutation responsible for the hypolipidemia. The hypl locus encodes a unique angiopoietin-like lipoprotein modulator, which we named Allm1. It is identical to angiopoietin-like protein 3, encoded by Angptl3, and has a highly conserved counterpart in humans. Overexpression of Angptl3 or intravenous injection of the purified protein in KK/San mice elicited an increase in circulating plasma lipid levels. This increase was also observed in C57BL/6J normal mice. Taken together, these data suggest that Angptl3 regulates lipid metabolism in animals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice
References
Stanbury, J.B., Wyngaarden, J.B., Goldstein, J.L. & Brown, M.S. in The Metabolic Basis of Inherited Disease 5th edn (eds Herbert, P.N., Assmann, G., Gotto, A.M. Jr & Fredrickson, D.S.) 589β621 (McGraw-Hill, New York, 1983).
Wetterau, J.R. et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258, 999β1001 (1992).
Shoulders, C.C. et al. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum. Mol. Genet. 2, 2109β2116 (1993).
Sharp, D. et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinemia. Nature 365, 65β69 (1993).
Rehberg, E.F. et al. A novel abetalipoproteinemia genotype. Identification of a missense mutation in the 97-kDa subunit of the microsomal triglyceride transfer protein that prevents complex formation with protein disulfide isomerase. J. Biol. Chem. 271, 29945β29952 (1996).
Narcisi, T.M. et al. Mutations of the microsomal triglyceride transfer-protein gene in abetalipoproteinemia. Am. J. Hum. Genet. 57, 1298β1310 (1995).
Farese, R.V., Linton, M.F. & Young, S.G. Apolipoprotein-B gene mutations affecting cholesterol levels. J. Int. Med. 231, 643β652 (1992).
Schonfeld, G. The hypobetalipoproteinemias. Annu. Rev. Nutr. 15, 23β34 (1995).
Talmud, P.J. et al. Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia. J. Lipid Res. 35, 468β477 (1994).
Welty, F.K., Ordovas, J., Schaefer, E.J., Wilson, P.W.F. & Young, S.G. Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels. Circulation 92, 2036β2040 (1995).
Parhofer, K.G., Barrett, P.H.R., Bier, D.M. & Schonfeld, G. Positive linear correlations between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes. J. Lipid Res. 37, 844β852 (1996).
Brooks-Wilson, A. et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nature Genet. 22, 336β345 (1999).
Bodzioch, M. et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nature Genet. 22, 347β351 (1999).
Rust, S. et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nature Genet. 22, 352β355 (1999).
Reue, K. & Doolittle, M.H. Naturally occurring mutations in mice affecting lipid transport and metabolism. J. Lipid Res. 37, 1387β1405 (1996).
Welsh, C.L. et al. Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes. J. Lipid Res. 37, 1406β1421 (1996).
Purcell-Huynh, D.A. et al. Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach. J. Clin. Invest. 96, 1845β1858 (1995).
Kondo, K., Nozawa, K., Tomita, T. & Ezaki, K. Inbred strains resulting from Japanese mice. Bulletin of the Experimental Animals 6, 107β112 (1957).
Nakamura, M. & Yamada, K. Studies on a diabetic (KK) strain of mice. Diabetologia 3, 212β221 (1967).
Nakamura, M. A diabetic strain of the mouse. Proc. Jpn. Acad. 38, 348β352 (1962).
Conklin, D. et al. Identification of mammalian angiopoietin-related protein expressed specifically in liver. Genomics 62, 477β482 (1999).
Shiraki, T., Yoshioka, S. & Horikoshi, H. Difference of triglyceride metabolism between two colonies of diabetic KK-mice. Diabetes Frontier 4, 641 (1993).
Fujiwara, T. et al. Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease. Genomics 54, 155β158 (1998).
Reaven, G.M. Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism 36, 1β8 (1987).
Greenfield, M., Kolterman, O., Olesfsky, J. & Reaven, G.M. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 18, 441β446 (1980).
Greenfield, M.S., Doberne, L., Rosenthal, M., Vreman, H.J. & Reaven, G.M. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy. Arch. Intern. Med. 142, 1498β1500 (1982).
Davis, S. et al. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell 87, 1161β1169 (1996).
Maisonpierre, P.C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55β60 (1997).
Valenzuela, D.M. et al. Angiopoietin 3 and 4: diverging gene counterparts in mice and humans. Proc. Natl Acad. Sci. USA 96, 1904β1909 (1999).
Procopio, W.N., Pelavin, P.I., Lee, W.M.F. & Yeilding, N.M. Angiopoietin-1 and β2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J. Biol. Chem. 274, 30196β30201 (1999).
Brunzell, J.D., Schrott, H.G., Motulsky, A.G. & Bierman, E.L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 25, 313β320 (1976).
Goldstein, J.L., Schrott, H.G., Hazzard, W.R., Bierman, E.L. & Motulsky, A.G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J.Clin. Invest. 52, 1544β1568 (1973).
Genest, J.J. Jr et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85, 2025β2033 (1992).
Schaefer, E.J., Genest, J.J. Jr, Ordovas, J.M., Salem, D.N. & Wilson, P.W. Familial lipoprotein disorders and premature coronary artery disease. Atherosclerosis 108, S41βS54 (1994).
Lander, E.S. et al. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1, 174β181 (1987).
Miyake, S. et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl Acad. Sci. USA 93, 1320β1324 (1996).
Kanegae, Y., Makimura, M. & Saito, I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47, 157β166 (1994).
Laemmli, U.K. Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature 227, 680β685 (1970).
Acknowledgements
This work is dedicated to the memory of N. Serizawa. We thank N. Shimizu and K. Kawasaki for help with BAC cloning; K. Maruyama for providing the pME18S vector; S. Takeshita, A. Suzuki and M. Ito for assistance with animal breeding and genetic analysis; M. Shimizu, A. Muramatsu, M. Mizuide, M. Sugawara, J. Ohsumi and S. Yoshioka for biochemical analysis; M. Nagata for anatomical analysis and K. Watanabe for protein purification. We are grateful to N. Nakamura, A. Sanbuissho and K. Yoshida for helpful discussion.
Supplementary information
Rights and permissions
About this article
Cite this article
Koishi, R., Ando, Y., Ono, M. et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 30, 151β157 (2002). https://doi.org/10.1038/ng814
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ng814
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
-
Generation of a familial hypercholesterolemia model in non-human primate
Scientific Reports (2023)
-
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
Cell Death & Disease (2023)
-
Chromatin regulator SMARCAL1 modulates cellular lipid metabolism
Communications Biology (2023)
-
ANGPTL4 stabilizes atherosclerotic plaques and modulates the phenotypic transition of vascular smooth muscle cells through KLF4 downregulation
Experimental & Molecular Medicine (2023)
-
Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
Lipids in Health and Disease (2022)
